159 related articles for article (PubMed ID: 1749291)
1. The potential for muscarinic receptor subtype-specific pharmacotherapy for Alzheimer's disease.
McKinney M; Coyle JT
Mayo Clin Proc; 1991 Dec; 66(12):1225-37. PubMed ID: 1749291
[TBL] [Abstract][Full Text] [Related]
2. Approaches to cholinergic therapy in Alzheimer's disease.
Iversen LL
Prog Brain Res; 1993; 98():423-6. PubMed ID: 8248531
[No Abstract] [Full Text] [Related]
3. Potential role of muscarinic agonists in Alzheimer's disease.
Avery EE; Baker LD; Asthana S
Drugs Aging; 1997 Dec; 11(6):450-9. PubMed ID: 9413702
[TBL] [Abstract][Full Text] [Related]
4. Subtype selective muscarinic agonists: potential therapeutic agents for Alzheimer's disease.
Davis R; Raby C; Callahan MJ; Lipinski W; Schwarz R; Dudley DT; Lauffer D; Reece P; Jaen J; Tecle H
Prog Brain Res; 1993; 98():439-45. PubMed ID: 8248534
[No Abstract] [Full Text] [Related]
5. On the physiological relevance of muscarinic acetylcholine receptors in Alzheimer's disease.
Koch HJ; Haas S; Jürgens T
Curr Med Chem; 2005; 12(24):2915-21. PubMed ID: 16305479
[TBL] [Abstract][Full Text] [Related]
6. Cognitive changes and modified processing of amyloid precursor protein in the cortical and hippocampal system after cholinergic synapse loss and muscarinic receptor activation.
Lin L; Georgievska B; Mattsson A; Isacson O
Proc Natl Acad Sci U S A; 1999 Oct; 96(21):12108-13. PubMed ID: 10518584
[TBL] [Abstract][Full Text] [Related]
7. Modulation of cellular excitability in neocortex: muscarinic receptor and second messenger-mediated actions of acetylcholine.
Cox CL; Metherate R; Ashe JH
Synapse; 1994 Feb; 16(2):123-36. PubMed ID: 7910986
[TBL] [Abstract][Full Text] [Related]
8. The cholinergic system in aging and neuronal degeneration.
Schliebs R; Arendt T
Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
[TBL] [Abstract][Full Text] [Related]
9. Cholinergic strategies in the treatment of Alzheimer's disease.
Davidson M; Stern RG; Bierer LM; Horvath TB; Zemishlani Z; Markofsky R; Mohs RC
Acta Psychiatr Scand Suppl; 1991; 366():47-51. PubMed ID: 1897375
[TBL] [Abstract][Full Text] [Related]
10. Muscarinic acetylcholine receptor expression in memory circuits: implications for treatment of Alzheimer disease.
Levey AI
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13541-6. PubMed ID: 8942969
[TBL] [Abstract][Full Text] [Related]
11. Muscarinic cholinergic agonists: pharmacological and clinical perspectives.
Palacios JM; Spiegel R
Prog Brain Res; 1986; 70():485-98. PubMed ID: 3554361
[No Abstract] [Full Text] [Related]
12. [Subtypes of muscarinic acetylcholine receptor following the experimental denervation of the cholinergic pathway ascending to the neocortex].
Pascual-Alonso T; González-Zárate JL
Arch Neurobiol (Madr); 1992; 55(3):116-23. PubMed ID: 1497416
[TBL] [Abstract][Full Text] [Related]
13. Muscarinic agonist therapy of Alzheimer's disease. A clinical trial of RS-86.
Bruno G; Mohr E; Gillespie M; Fedio P; Chase TN
Arch Neurol; 1986 Jul; 43(7):659-61. PubMed ID: 3524514
[TBL] [Abstract][Full Text] [Related]
14. The utility of muscarinic agonists in the treatment of Alzheimer's disease.
Messer WS
J Mol Neurosci; 2002; 19(1-2):187-93. PubMed ID: 12212779
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic receptors and novel strategies for the treatment of age-related brain disorders.
Ehlert FJ; Roeske WR; Yamamura HI
Life Sci; 1994; 55(25-26):2135-45. PubMed ID: 7997072
[TBL] [Abstract][Full Text] [Related]
16. The cholinergic system, circadian rhythmicity, and time memory.
Hut RA; Van der Zee EA
Behav Brain Res; 2011 Aug; 221(2):466-80. PubMed ID: 21115064
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of the novel cholinomimetic L-689,660 at cloned and native brain muscarinic receptors.
Aagaard P; McKinney M
J Pharmacol Exp Ther; 1993 Dec; 267(3):1478-83. PubMed ID: 8263809
[TBL] [Abstract][Full Text] [Related]
18. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease.
Fisher A; Brandeis R; Karton I; Pittel Z; Gurwitz D; Haring R; Sapir M; Levy A; Heldman E
J Pharmacol Exp Ther; 1991 Apr; 257(1):392-403. PubMed ID: 2019998
[TBL] [Abstract][Full Text] [Related]
19. Muscarinic and nicotinic modulation of cortical acetylcholine release monitored by in vivo microdialysis in freely moving adult rats.
Quirion R; Richard J; Wilson A
Synapse; 1994 Jun; 17(2):92-100. PubMed ID: 8091306
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
